Real-world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis

J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e796-e798. doi: 10.1111/jdv.20660. Epub 2025 Mar 25.

Authors

Teppei Hagino¹, Akihiko Uchiyama², Keiji Kosaka², Takeshi Araki², Hidehisa Saeki³, Eita Fujimoto⁴, Sei-Ichiro Motegi², Naoko Kanda¹

Affiliations

¹ Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
² Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan.
³ Department of Dermatology, Nippon Medical School, Tokyo, Japan.
⁴ Fujimoto Dermatology Clinic, Funabashi, Japan.

PMID: 40130939
DOI: 10.1111/jdv.20660

No abstract available

Publication types

Letter

Grants and funding